[
  {
    "ts": null,
    "headline": "Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e562aa455c4d5042d8a4f72ce87d24952517a4b03c2918fcf624c67e66a38292",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753979700,
      "headline": "Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors",
      "id": 136168852,
      "image": "",
      "related": "ISRG",
      "source": "MarketWatch",
      "summary": "Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e562aa455c4d5042d8a4f72ce87d24952517a4b03c2918fcf624c67e66a38292"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical (ISRG) Soared on Solid Financial Results",
    "summary": "Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care […]",
    "url": "https://finnhub.io/api/news?id=fbd4024c66a34c9f85ffe95a5e40b92c1785627baac14b7c0190829de5bba903",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753963687,
      "headline": "Intuitive Surgical (ISRG) Soared on Solid Financial Results",
      "id": 136151871,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care […]",
      "url": "https://finnhub.io/api/news?id=fbd4024c66a34c9f85ffe95a5e40b92c1785627baac14b7c0190829de5bba903"
    }
  },
  {
    "ts": null,
    "headline": "Franklin U.S. Focused Growth SMA Q2 2025 Commentary",
    "summary": "Franklin U.S. Focused Growth SMA Q2 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=3c4d4097098efdf7315096b4337dd1f968ae5eb2b3a3f20b740f8198f5ff556e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753960200,
      "headline": "Franklin U.S. Focused Growth SMA Q2 2025 Commentary",
      "id": 136154637,
      "image": "",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=3c4d4097098efdf7315096b4337dd1f968ae5eb2b3a3f20b740f8198f5ff556e"
    }
  },
  {
    "ts": null,
    "headline": "Franklin DynaTech SMA Q2 2025 Commentary",
    "summary": "Franklin Templeton reports strong Q2 gains led by tech and selective stock picks. See how AI and innovation are shaping their outlook. Read the full update.",
    "url": "https://finnhub.io/api/news?id=7c93f3541e894bd4df214dac6bf5adfc913915794a006af96ff664728b295780",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753959600,
      "headline": "Franklin DynaTech SMA Q2 2025 Commentary",
      "id": 136154182,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/974479826/image_974479826.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "Franklin Templeton reports strong Q2 gains led by tech and selective stock picks. See how AI and innovation are shaping their outlook. Read the full update.",
      "url": "https://finnhub.io/api/news?id=7c93f3541e894bd4df214dac6bf5adfc913915794a006af96ff664728b295780"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Consider Right Now and 2 That Underwhelm",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 14.2%. This drawdown is a noticeable divergence from the S&P 500’s 5.4% return.",
    "url": "https://finnhub.io/api/news?id=a2637b358ff67a726c6b6fff273997a424678737398fa2b1734c9c17e399a5d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753936357,
      "headline": "1 Healthcare Stock to Consider Right Now and 2 That Underwhelm",
      "id": 136161021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 14.2%. This drawdown is a noticeable divergence from the S&P 500’s 5.4% return.",
      "url": "https://finnhub.io/api/news?id=a2637b358ff67a726c6b6fff273997a424678737398fa2b1734c9c17e399a5d2"
    }
  }
]